Avax Technologies, Inc., (AVXT) announced the presentation of data at the 93rd Annual Meeting of the American Association for Cancer Research (AACR) entitled "Sequence analysis of T cell receptors of lymphocytes infiltrating melanoma metastases after administration of autologous, dinitrophenyl (DNP)-modified vaccine." The study, utilizing new analytical techniques on cells collected in previous clinical trials, indicates that Avax's DNP modified autologous melanoma cell vaccine induced a unique immunological response within the patients' tumors.
Avax's DNP modified autologous melanoma cell vaccine is a therapeutic vaccine for metastatic melanoma made from a patient's...
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry